Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 1298 Radiomics features to pre...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
1298 Radiomics features to predict immune checkpoint inhibitor-related pneumonitis (CIP) in NSCLC patients treated with immunotherapy

1298 Radiomics features to predict immune checkpoint inhibitor-related pneumonitis (CIP) in NSCLC patients treated with immunotherapy

Bibliographic Details
Main Authors: Young Kwang Chae, Myungwoo Nam, Youjin Oh, Leeseul Kim, Timothy Hong, Liam Il-Young Chung, Soowon Lee, Sung Mi Yoon, Trie Arni Djunadi, Taegyu Um, Jeeyeon Lee, Maria Jose Aguilera Chuchuca, Madeline Jenkin, Jisang Yu, Hyeonseon Kim, Moataz Soliman, Nicolo Gennaro, Zunairah Shah, Cecilia Nam, Yury S Velichko, Haseok Kim
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 1299 Radiomics features to predict tumor response and biomarker status in non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    by: Young Kwang Chae, et al.
    Published: (2023-11-01)
  • Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review
    by: Youjin Oh, et al.
    Published: (2024-01-01)
  • 38 Serum proteomics signature and its association with immune-related toxicities and survival in patients with non-small cell lung cancers (NSCLC) receiving immunotherapy
    by: Young Kwang Chae, et al.
    Published: (2023-11-01)
  • CIP
    by: - -
    Published: (2012-12-01)
  • CIP
    by: - -
    Published: (2012-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs